A Safety Study of ABBV-243 in Healthy Adults
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your body mass index (BMI) must be between 18.0 and 32.0.
- If you are a woman who can get pregnant, you cannot be pregnant or breastfeeding, and you must agree to use highly effective birth control for 200 days after the last dose. Women who cannot get pregnant (e.g., after menopause or surgery) are also eligible.
- You must not have a history of epilepsy, serious heart, lung, kidney, liver, or other major illnesses or cancer (except certain minor skin cancers).
- For part of the study, you must be of Japanese or Han Chinese descent (born in that country or of full parentage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This trial tests an experimental oral drug (called ABBV-1162) in healthy adults to see how the body handles it and to check for any side effects. It is one of the first steps in testing a new medicine.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.